Upgrades, downgrades, and outlook changes from major analysts.
Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.
1,312 total articles
Ally Financial's shares held steady around $42 after Truist Securities reaffirmed a Buy rating with a $51 price target. The company outlined outlooks for net interest margin and retail auto net charge-offs that slightly missed analyst expectations, provoking mixed views on the conservative tone of guidance. Despite this, the company maintains a sol…
Stephens has updated its outlook for Wintrust Financial by raising the price target from $158 to $162, reflecting confidence in the bank's continued growth driven by a differentiated business model and strong fourth-quarter and full-year 2025 performance. The firm maintains an Overweight rating, underpinned by rising loans and deposits, solid reven…
Stephens has adjusted its price target for EQT Corp. from $69.00 down to $68.00 while maintaining an Overweight rating on the natural gas company. Despite the slight decrease in price target, EQT's shares still present a significant upside relative to current trading levels. The revision incorporates modest downward revisions in production and cash…
DA Davidson has elevated its price target for Dime Community Bancshares, signaling confidence in the bank’s ongoing growth and profitability. The firm maintains a Buy rating following the bank's impressive fourth-quarter earnings and strategic financial improvements, including revenue growth and net interest margin expansion. The bank’s focus on hi…
Stephens has revised down its price target for Calavo Growers to $27.00 from $28.00, maintaining an Equal Weight rating. This adjustment follows Calavo's fourth-quarter performance, where underperformance in its Fresh business weighed on results despite strength in Prepared foods. Meanwhile, the planned acquisition by Mission Produce is seen as a s…
TD Cowen has maintained its bullish stance on Alphabet, upholding a Buy rating and a $355 price target fueled by optimistic projections for Waymo's autonomous vehicle service expansion. The firm anticipates that by 2026, Waymo will operate thousands of vehicles delivering millions of paid rides across multiple urban centers, reflecting a strategic …
TD Cowen reaffirms its positive stance on Lyft, maintaining a Buy rating with a $32 price target driven by expectations for robust revenue growth and expanded gross bookings. Anticipated drivers include contributions from recent acquisitions, partnerships, and regional market expansion. Investor focus is anticipated on rideshare trends and margin i…
DA Davidson analysts have increased their price forecast for Simmons First National to $23 from $21, driven by the bank's impressive fourth-quarter results which featured higher than expected net interest margin expansion. While this suggests a stronger financial footing heading into 2026, the firm holds a Neutral rating, reflecting balanced consid…
TD Cowen has increased its price target for Charles Schwab Corporation from $135 to $138, reflecting confidence in the firm's strong fourth-quarter results and optimistic earnings projections for 2026 and 2027. Schwab's stock currently trades near its annual high, supported by favorable earnings estimates and solid client cash dynamics. Other major…
TD Cowen has reaffirmed its Buy rating on Ally Financial, setting a price target of $55, which implies notable potential gains from current trading levels. The firm’s optimism follows a quarterly earnings report that surpassed estimates, driven by increased other revenue, despite some downward adjustments in future earnings projections. The outlook…
DA Davidson has upheld its Neutral rating and $110 price objective for Pinnacle Financial Partners following strong quarterly performance and the completion of its merger with Synovus Financial. Key metrics such as double-digit loan and deposit growth, consistent net interest margins, and improved credit quality underpin the current valuation persp…
TD Cowen has increased its price target for Johnson & Johnson to $250, citing impressive fourth-quarter revenue and promising guidance for 2026. Other financial institutions also upgraded their outlooks based on the company's solid sales and earnings results, reflecting positive sentiment toward the healthcare company's sustained growth.
